Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone enanthate in men with chronic obstructive pulmonary disease
IRCT20180805040708N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of testosterone enanthate in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Change in hormonal tests, Change in pulmonary function test and 4 more. Started Aug 2018; status: completed.
02
Drugs
testosterone enanthate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on IRCT20180805040708N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180805040708N1.